Bloomberg

Two major Chinese solar manufacturers have been approved to build silicon wafer plants in Sichuan province, responding to tight supply and rising domestic demand for renewable energy materials.

The People’s Bank of China (PBOC) announced it will suspend government bond purchases this month due to a supply-demand imbalance, as bond supply has fallen short of demand.

Bridgewater Associates, the world’s largest hedge fund, dismissed approximately 7% of its workforce, totaling around 90 employees, to stay lean and maintain hiring flexibility.

Steve Diggle’s Vulpes Investment Management is preparing to capitalize on market volatility, aiming to raise up to $250 million from investors as early as the first quarter of 2025.

Guyana is actively clearing wreckage from its waterways to enhance navigation as ship traffic increases to support the growing oil sector.

South Africa is set to attract Chinese investment in its $27 billion automotive industry following the approval of a tax break for new-energy vehicle production.

Pan African Resources Plc has emerged as South Africa's best-performing miner this year, challenging the nation's reputation for expensive and declining gold production.

AT&T and Verizon have confirmed being targeted by the China-linked Salt Typhoon hacking operation, which aimed to extract intelligence on foreign political and intelligence figures.

Iron ore prices dropped below $100 a ton, hitting their lowest level in over five weeks, amid concerns about China's economic weakness.

Eskom Holdings SOC Ltd.’s non-guaranteed bonds are seeing their risk premium drop to the lowest level since their issuance in 2018. This reflects growing investor confidence in the utility's turnaround efforts, fueled by a focus on returning to profitability and reducing debt.

Cocoa futures hit a new record in New York, climbing 5.5% to $11,925 per ton on Monday, surpassing the previous high of $11,722 set in April. This surge reflects growing supply concerns as the crop outlook for West Africa, a key cocoa-producing region, worsens.

Novo Nordisk A/S, the maker of Ozempic, is investing 8.5 billion kroner ($1.2 billion) to construct a large factory in Denmark to address rising demand for its popular drugs.